Literature DB >> 17459810

Vaccine-induced pathogen strain replacement: what are the mechanisms?

Maia Martcheva1, Benjamin M Bolker, Robert D Holt.   

Abstract

Host immune systems impose natural selection on pathogen populations, which respond by evolving different antigenic signatures. Like many evolutionary processes, pathogen evolution reflects an interaction between different levels of selection; pathogens can win in between-strain competition by taking over individual hosts (within-host level) or by infecting more hosts (population level). Vaccination, which intensifies and modifies selection by protecting hosts against one or more pathogen strains, can drive the emergence of new dominant pathogen strains-a phenomenon called vaccine-induced pathogen strain replacement. Here, we review reports of increased incidence of subdominant variants after vaccination campaigns and extend the current model for pathogen strain replacement, which assumes that pathogen strain replacement occurs only through the differential effectiveness of vaccines against different pathogen strains. Based on a recent theoretical study, we suggest a broader range of possible mechanisms, some of which allow pathogen strain replacement even when vaccines are perfect-that is, they protect all vaccinated individuals completely against all pathogen strains. We draw an analogy with ecological and evolutionary explanations for competitive dominance and coexistence that allow for tradeoffs between different competitive and life-history traits.

Mesh:

Substances:

Year:  2008        PMID: 17459810      PMCID: PMC2405901          DOI: 10.1098/rsif.2007.0236

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  57 in total

1.  Host heterogeneity and disease endemicity: a moment-based approach.

Authors:  J Dushoff
Journal:  Theor Popul Biol       Date:  1999-12       Impact factor: 1.570

2.  A competitive exclusion principle for pathogen virulence.

Authors:  H J Bremermann; H R Thieme
Journal:  J Math Biol       Date:  1989       Impact factor: 2.259

3.  Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

Authors:  Susan S Huang; Richard Platt; Sheryl L Rifas-Shiman; Stephen I Pelton; Donald Goldmann; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

4.  Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands.

Authors:  Leo M Schouls; Arie van der Ende; Ingrid van de Pol; Corrie Schot; Lodewijk Spanjaard; Paul Vauterin; Dorus Wilderbeek; Sandra Witteveen
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group.

Authors:  G Urwin; J A Krohn; K Deaver-Robinson; J D Wenger; M M Farley
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

6.  Human immunodeficiency virus drug therapy and virus load.

Authors:  S Bonhoeffer; J M Coffin; M A Nowak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.

Authors:  Xiaodong Zhao; Enmei Liu; Fu-Ping Chen; Wayne M Sullender
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

9.  An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001-2002.

Authors:  Koen De Schrijver; Inge Maes
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

10.  Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999.

Authors:  Terri Hawes Hardwick; Pamela Cassiday; Robbin S Weyant; Kristine M Bisgard; Gary N Sanden
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

View more
  24 in total

1.  Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions.

Authors:  Virginia E Pitzer; Manish M Patel; Ben A Lopman; Cécile Viboud; Umesh D Parashar; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  When co-colonizing the nasopharynx haemophilus influenzae predominates over Streptococcus pneumoniae except serotype 19A strains to cause acute otitis media.

Authors:  Qingfu Xu; Janet R Casey; Arthur Chang; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

3.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

4.  The evolutionary consequences of alternative types of imperfect vaccines.

Authors:  Krisztian Magori; Andrew W Park
Journal:  J Math Biol       Date:  2013-02-28       Impact factor: 2.259

5.  No coexistence for free: neutral null models for multistrain pathogens.

Authors:  Marc Lipsitch; Caroline Colijn; Ted Cohen; William P Hanage; Christophe Fraser
Journal:  Epidemics       Date:  2008-11-04       Impact factor: 4.396

6.  Use of massively parallel pyrosequencing to evaluate the diversity of and selection on Plasmodium falciparum csp T-cell epitopes in Lilongwe, Malawi.

Authors:  Jeffrey A Bailey; Tisungane Mvalo; Nagesh Aragam; Matthew Weiser; Seth Congdon; Debbie Kamwendo; Francis Martinson; Irving Hoffman; Steven R Meshnick; Jonathan J Juliano
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

7.  Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines.

Authors:  Ted Cohen; Caroline Colijn; Megan Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-10       Impact factor: 11.205

8.  HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.

Authors:  Joshua T Herbeck; Kathryn Peebles; Paul T Edlefsen; Morgane Rolland; James T Murphy; Geoffrey S Gottlieb; Neil Abernethy; James I Mullins; John E Mittler; Steven M Goodreau
Journal:  Vaccine       Date:  2017-12-11       Impact factor: 3.641

9.  Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.

Authors:  Joseph E Tota; Agnihotram V Ramanakumar; Mengzhu Jiang; Joakim Dillner; Stephen D Walter; Jay S Kaufman; François Coutlée; Luisa L Villa; Eduardo L Franco
Journal:  Am J Epidemiol       Date:  2013-05-09       Impact factor: 4.897

Review 10.  Broad vaccine protection against Neisseria meningitidis using factor H binding protein.

Authors:  Jamie Findlow; Christopher D Bayliss; Peter T Beernink; Ray Borrow; Paul Liberator; Paul Balmer
Journal:  Vaccine       Date:  2020-08-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.